Novaccess Global

About:

Novaccess Global brings together technological assets, scientific, and executive team to accelerate taking these assets to market.

Website: https://novaccessglobal.com/

Top Investors: Sumner Global

Description:

NovAccess Global is building long-term shareholder value through the intelligent acquisition of assets in clinical-stage research and development, balanced with medical assets in the market. The company brings together technological assets, scientific, and executive team to accelerate taking these assets to market.

Total Funding Amount:

$10.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chesterland, Ohio, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)novaccessglobal.com

Founders:

Dr. Dwain Irvin

Number of Employees:

1-10

Last Funding Date:

2024-01-02

IPO Status:

Public

Industries:

© 2025 bioDAO.ai